Discontinued — last reported Q4 '25
Year-over-year, this metric declined by 100.0%, from $16.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Any non-zero value is a negative signal, indicating that previous acquisitions or business valuations were overly optimistic.
Represents a non-cash charge taken when the carrying value of goodwill associated with the Pharma Solutions segment exce...
Reported by companies following M&A activity when segment performance fails to meet acquisition-time projections.
iff_segment_pharma_solutions_impairment_of_goodwill| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $16.00M | $16.00M | $16.00M | $16.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | -100.0% | -100.0% | -100.0% | -100.0% |